VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+15.01%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$115M
AUM Growth
+$35.6M
(+45%)
Cap. Flow
+$32.6M
Cap. Flow
% of AUM
28.25%
Top 10 Holdings %
Top 10 Hldgs %
16.88%
Holding
267
New
23
Increased
109
Reduced
60
Closed
21
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.4M |
| 2 |
Geron
GERN
|
$870K |
| 3 |
Iovance Biotherapeutics
IOVA
|
$856K |
| 4 |
iShares MSCI India ETF
INDA
|
$838K |
| 5 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$759K |
Top Sells
| 1 |
ProShares Ultra Utilities
UPW
|
$1.12M |
| 2 |
Vanguard Energy ETF
VDE
|
$721K |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$612K |
| 4 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
$421K |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$359K |
Sector Composition
| 1 | Healthcare | 78.8% |
| 2 | Financials | 0.81% |
| 3 | Technology | 0.52% |
| 4 | Consumer Discretionary | 0.44% |
| 5 | Communication Services | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
26
DELISTED
Radius Health, Inc.
RDUS
| $1.12M | 0.97% |
31,013
-1,850
| -6% | -$66.5K |
|
|
MDCO
27
DELISTED
Medicines Co
MDCO
| $1.1M | 0.95% |
33,271
-1,946
| -6% | -$64.1K |
|
28
Karyopharm Therapeutics
KPTI
$58.4M
| $1.09M | 0.95% |
5,422
+2,957
| +120% | +$595K |
|
29
Vanda Pharmaceuticals
VNDA
$274M
| $1.08M | 0.94% |
64,040
-3,773
| -6% | -$63.6K |
|
|
LOXO
30
DELISTED
Loxo Oncology, Inc
LOXO
| $1.08M | 0.94% |
9,346
+4,922
| +111% | +$568K |
|
31
Neurocrine Biosciences
NBIX
$13.9B
| $1.07M | 0.93% |
12,899
-753
| -6% | -$62.5K |
|
32
Xencor
XNCR
$597M
| $1.07M | 0.92% |
35,554
+19,240
| +118% | +$577K |
|
|
ITCI
33
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.05M | 0.91% |
50,088
+26,986
| +117% | +$568K |
|
|
34
Vanguard Energy ETF
VDE
$7.33B
| $1.05M | 0.91% |
11,398
-7,801
| -41% | -$721K |
|
|
EPZM
35
DELISTED
Epizyme, Inc
EPZM
| $1.05M | 0.91% |
59,330
+31,789
| +115% | +$564K |
|
36
Kura Oncology
KURA
$706M
| $1.04M | 0.9% |
55,283
+29,635
| +116% | +$556K |
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $1.03M | 0.9% |
6,334
-484
| -7% | -$78.9K |
|
|
ACOR
38
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $1.03M | 0.9% |
364
-21
| -5% | -$59.5K |
|
|
AKCA
39
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $1.01M | 0.87% |
39,351
+21,280
| +118% | +$545K |
|
40
Voyager Therapeutics
VYGR
$215M
| $1M | 0.87% |
53,407
+29,821
| +126% | +$561K |
|
|
AGEN
41
Agenus
AGEN
$137M
| $1M | 0.87% |
10,829
+5,823
| +116% | +$538K |
|
42
uniQure
QURE
$973M
| $999K | 0.87% |
42,504
+22,662
| +114% | +$533K |
|
43
CytomX Therapeutics
CTMX
$346M
| $992K | 0.86% |
34,876
+18,817
| +117% | +$535K |
|
44
MacroGenics
MGNX
$123M
| $988K | 0.86% |
39,254
+21,197
| +117% | +$534K |
|
45
Vanguard Real Estate ETF
VNQ
$34.3B
| $976K | 0.85% |
12,936
+4,475
| +53% | +$338K |
|
|
ACHN
46
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $973K | 0.84% |
262,284
+141,020
| +116% | +$523K |
|
|
MYOK
47
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $957K | 0.83% |
19,602
+10,155
| +107% | +$496K |
|
48
Dynavax Technologies
DVAX
$1.17B
| $951K | 0.83% |
47,898
-2,828
| -6% | -$56.1K |
|
49
Gilead Sciences
GILD
$140B
| $946K | 0.82% |
12,546
-742
| -6% | -$55.9K |
|
|
AVXS
50
DELISTED
AveXis, Inc. Common Stock
AVXS
| $938K | 0.81% |
7,590
+4,126
| +119% | +$510K |
|